These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33329388)

  • 1. Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease.
    Hannibal L; Theimer J; Wingert V; Klotz K; Bierschenk I; Nitschke R; Spiekerkoetter U; Grünert SC
    Front Endocrinol (Lausanne); 2020; 11():579981. PubMed ID: 33329388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases.
    Liang Y; Du C; Wei H; Zhang C; Zhang M; Hu M; Fang F; Luo X
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1444. PubMed ID: 32772503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.
    Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
    Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ
    Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).
    Mishra K; Kakhlon O
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Characteristics of Pediatric Glycogen Storage Disease.
    Muzetti JH; do Valle DA; Santos MLSF; Telles BA; Cordeiro ML
    Front Endocrinol (Lausanne); 2021; 12():685272. PubMed ID: 34093448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
    Shin YS
    Semin Pediatr Neurol; 2006 Jun; 13(2):115-20. PubMed ID: 17027861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J; Waskowicz LR; Lim A; Liao XH; Lian B; Masamune H; Refetoff S; Tran B; Koeberl DD; Yen PM
    Thyroid; 2019 Aug; 29(8):1158-1167. PubMed ID: 31337282
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of minimally invasive
    Turki A; Stockler S; Sirrs S; Salvarinova R; Ho G; Branov J; Rosen-Heath A; Bosdet T; Elango R
    Mol Genet Metab Rep; 2022 Jun; 31():100880. PubMed ID: 35585965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    J Trace Elem Med Biol; 2010 Jan; 24(1):42-5. PubMed ID: 20122579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study.
    Chan YC; Liu KM; Chen CL; Ong AD; Lin CC; Yong CC; Tsai PC; Lu LS; Wu JY
    Orphanet J Rare Dis; 2021 Oct; 16(1):423. PubMed ID: 34635148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired carbohydrate metabolism of polymorphonuclear leukocytes in glycogen storage disease Ib.
    Bashan N; Hagai Y; Potashnik R; Moses SW
    J Clin Invest; 1988 May; 81(5):1317-22. PubMed ID: 3163346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen storage diseases: new perspectives.
    Ozen H
    World J Gastroenterol; 2007 May; 13(18):2541-53. PubMed ID: 17552001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of histological criteria in glycogen storage disease of the liver.
    Jevon GP; Finegold MJ
    Pediatr Pathol; 1994; 14(4):709-21. PubMed ID: 7971588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise in muscle glycogen storage diseases.
    Preisler N; Haller RG; Vissing J
    J Inherit Metab Dis; 2015 May; 38(3):551-63. PubMed ID: 25326273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.
    Slonim AE; Coleman RA; Moses S; Bashan N; Shipp E; Mushlin P
    Metabolism; 1983 Jan; 32(1):70-4. PubMed ID: 6336817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX.
    Geberhiwot T; Alger S; McKiernan P; Packard C; Caslake M; Elias E; Cramb R
    J Inherit Metab Dis; 2007 Jun; 30(3):406. PubMed ID: 17407002
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.